Crown v. Nissan North American, Inc.

634 F. Supp. 2d 688, 2009 U.S. Dist. LEXIS 47633, 2009 WL 1609051
CourtDistrict Court, S.D. Mississippi
DecidedJune 8, 2009
DocketCase 3:08CV418TSL-JCS
StatusPublished

This text of 634 F. Supp. 2d 688 (Crown v. Nissan North American, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Mississippi primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Crown v. Nissan North American, Inc., 634 F. Supp. 2d 688, 2009 U.S. Dist. LEXIS 47633, 2009 WL 1609051 (S.D. Miss. 2009).

Opinion

MEMORANDUM OPINION AND ORDER

TOM S. LEE, District Judge.

This cause is before the court on the motion of defendant Nissan North America, Inc. (Nissan) for summary judgment pursuant to Rule 56 of the Federal Rules of Civil Procedure. Plaintiff Jeremy Crown has responded to the motion and the court, having considered the memoranda of authorities, together with attachments, submitted by the parties, concludes that the motion is well taken and should be granted.

In this action, plaintiff alleges he was terminated from his employment with Nissan in violation of the Family Medical Leave Act, 29 U.S.C. § 2601 et seq. (FMLA). 1 Specifically, plaintiff, who was diagnosed with diabetes in August 2006, alleges that in October 2007, he requested approval for three days of FMLA leave for a diabetes-related condition or illness, which Nissan wrongly denied; and because Nissan refused to approve his request for FMLA leave, he was charged with three days’ unexcused/unapproved absence from work, which Nissan ultimately asserted as grounds for his subsequent termination in January 2008. For its part, Nissan takes the position that plaintiffs October 2007 absences cannot form the basis of a viable FMLA claim because plaintiff failed to comply with Nissan’s policy which required that he provide notice and a medical certification demonstrating that the leave was covered by the FMLA, and that consequently, plaintiff was not entitled to FMLA leave for those absences. It is on this basis that Nissan has moved for summary judgment.

The following facts are undisputed: Plaintiff became employed by Nissan as a production technician in 2003. In August 2006, plaintiff became severely ill and was hospitalized, causing him to be absent from work for ten days. At that time, plaintiff was diagnosed with Type 1 Diabetes. When he returned to work on August 15, 2006, plaintiff completed Nissan’s “Employee’s Request for FMLA Designation of Time Off,” listing “Diabetes Condition” as the “Reason for Request.” That request was accompanied by a “Certification of Health Care Provider,” on which his doctor indicated that plaintiff suffered from a “chronic condition” that would be of indefinite duration and for which plaintiff would “need the ability to stop for snacks and check his sugar as needed.” Nissan approved plaintiffs absence as protected, FMLA leave. 2

*690 The following October, plaintiff was absent from work for three days, October 24, 25 and 26. Plaintiff maintains that this period of absence was related to an illness resulting from his diabetes, and upon returning to work on October 27, he filed the required documents to request FMLA leave. On the form, plaintiff cited “illness” as the reason for request, for which he had sought treatment at an MEA Medical Clinic. As the basis for claiming the absence as FMLA protected, the accompanying certification completed by MEA indicated that plaintiffs illness lasted more than three days (which would have made it protected FMLA leave, see infra). However, that was obviously incorrect, since plaintiff was absent for only three days. Accordingly, Nissan denied plaintiffs request for approval of FMLA leave. His absence was thus unprotected and therefore, based on Nissan’s Attendance Corrective Action Guidelines, pursuant to which employees are assessed attendance points for unexcused and excused (but unpaid and unprotected) absences, plaintiff was assessed four points, which brought his attendance point total to twelve. 3

According to Nissan, thereafter, in December 2007, pursuant to the company’s normal practice of monitoring employee attendance, Nissan conducted an investigation of plaintiffs attendance status. The investigation concluded that under the company’s Attendance Corrective Action Guidelines, plaintiffs attendance point total of twelve justified a “Written Reminder”; and further, since plaintiff had been issued a “Final Written Reminder” in May 2007 as the result of numerous successive conduct infractions, then pursuant to Nissan’s progressive corrective action system, his incurrence of a Written Reminder for violation of the Attendance Policy within a year of the May 2007 Final Written Reminder warranted his termination. 4

Under the FMLA, an eligible employee is entitled to a total of 12 weeks of leave a year for, inter alia, a “serious health condition that makes the employee unable to perform the functions of the position of such employee”. 29 U.S.C. § 2612(a)(1)(D). Applicable Department of Labor (DOL) regulations define “serious health condition” as “an illness, injury, impairment, or physical or mental condition” that involves inpatient care or continuing treatment by a health care provider. 29 C.F.R. § 825.114(a)(2). A serious health condition involving continuing treatment *691 by a health care provider is further defined to include, inter alia, “[a] period of incapacity ... of more than three consecutive calendar days,” and “[a]ny period of incapacity or treatment for such incapacity due to a chronic serious health condition.” § 825.114(a)(2)(i) and (iii). The definition of “chronic serious health condition” includes a health condition which “[m]ay cause episodic rather than a continuing period of incapacity (e.g., asthma, diabetes, epilepsy, etc.).” § 825.114(a)(2)(iii)(C) (emphasis added).

The FMLA “protects employees from interference with their leave as well as against discrimination or retaliation for exercising their rights.” Bocalbos v. Nat’l W. Life Ins. Co., 162 F.3d 379, 383 (5th Cir.1998); see 29 U.S.C. § 2615(a) (covered employer may not “interfere with, restrain, or deny the exercise of or the attempt to exercise, any [FMLA leave] right,” or otherwise “discriminate against any individual for opposing any [FMLA-prohibited] practice”). Although the term “interference” is not defined in the FMLA, DOL regulations explain that “[i]interfering with the exercise of an employee’s rights would include, for example, not only refusing to authorize FMLA leave, but discouraging an employee from using such leave.” 29 C.F.R. § 825.220. See Duchesne v. Shaw Group Inc., Civil Action No. 06-607, 2008 WL 4544387, 4 (WD.La. Sept. 10, 2008). To survive summary judgment on his interference claim, 5 plaintiff must first establish a prima facie case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Comeaux-Bisor v. YMCA of Greater Houston
290 F. App'x 722 (Fifth Circuit, 2008)
Ford-Evans v. United Space Alliance LLC
329 F. App'x 519 (Fifth Circuit, 2009)
Melanie Satterfield v. Wal-Mart Stores, Inc.
135 F.3d 973 (Fifth Circuit, 1998)
Marquita Phillips v. Quebecor World Rai Incorporated
450 F.3d 308 (Seventh Circuit, 2006)
De La Rama v. Illinois Department of Human Services
541 F.3d 681 (Seventh Circuit, 2008)
Basso v. Potter
596 F. Supp. 2d 324 (D. Connecticut, 2009)
Brown v. the Pension Boards
488 F. Supp. 2d 395 (S.D. New York, 2007)
Throneberry v. McGehee Desha County Hospital
403 F.3d 972 (Eighth Circuit, 2005)
United States v. Espinoza-Segundo
296 F. App'x 383 (Fifth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
634 F. Supp. 2d 688, 2009 U.S. Dist. LEXIS 47633, 2009 WL 1609051, Counsel Stack Legal Research, https://law.counselstack.com/opinion/crown-v-nissan-north-american-inc-mssd-2009.